Healthquad raises Rs. 750 million to support thematic healthcare companies in India

New Delhi [India] June 15 : India's leading specialist healthcare focused venture capital fund 'Healthquad' has achieved its final close with a total commitment of Rs.

750 million for investing in thematic and disruptive healthcare business models in the country. The Fund is also the first early stage investment vehicle by the leading healthcare private equity investors Amit Varma, Abrar Mir and Charles Antione Janssen.

Delhi-based venture capital firm garners strong investor interest from accomplished healthcare professionals and investors and leading institutions from Europe.

The Fund targets to invest around four billion rupees in healthcare companies that have the potential to disrupt the healthcare landscape by improving the productivity, affordability and accessibility of healthcare through differentiated and innovative solutions.

Fund's sponsor Amit Varma said, "Healthcare sector has seen emergence of over 500 startups in the last two years and venture capital firms have infused around 25 billion rupees.

We are looking to deploy around four billion rupees, along with co-investors and partner funds in healthcare models that are driven by new age disruptive technology and are changing the way healthcare is delivered and accessed in India." "Our deployments in healthcare across sub-sectors and geographies provide extensive synergies to help companies scale-up rapidly and that forms the basis of our compelling proposition to healthcare entrepreneurs in India," Fund's co-sponsor Abrar Mir added.

Lastly, Charles Antione Janssen, Fund's third co-sponsor said, "Our first four Healthquad investments have confirmed that business model innovations and health tech innovations will open access to quality healthcare for hundreds of millions of neglected Indians.

Our final close will allow us to fund more, fast growing, profitable and highly impactful companies. We look forward to supporting great entrepreneurs for the benefit of patients as well as our LPs.".

Source: ANI